Melanoma March 2016 is launched

Melanoma March 2016 is launched

2 February 2016

Melanoma Institute Australia (MIA) officially launched the 2016 ‘Melanoma March’ initiative in Sydney today.

The launch event held at the Sofitel Sydney Wentworth revealed plans for the new project that will receive funds from this year's Melanoma March campaign. Channel 7's Dr. Andrew Rochford hosted the event, with MIA"s new CEO Carole Renouf helping to get the campaign off to a flying start. Melanoma patient and author of Dear Melanoma Emma Betts also spoke passionately about the importance of research. 

Professor Graham Mann, Research Director at MIA, explained how the Melanoma March campaign provides critical funding for an ambitious new project that will ultimately transform the way patients are treated by shining a research light on melanoma care.

Participating melanoma centres around the country will link databases, for the first time bringing together the key information about the treatment of their patients on a national scale. At present melanoma is only recorded by national cancer registries at the time it is initially diagnosed. Data suitable for research about the patients’ treatment and progress is currently only collected in a few specialist centres. This project seeks to expand this substantially and facilitate the appropriate combination of this invaluable information to provided new insights into treatment responses, especially with the less common forms of melanoma where our aggregated national experience will be so informative. 

The world-leading ‘Big Data for Melanoma’ project will feature an online platform designed to engage with melanoma care, wherever it takes place.

“With melanoma cases still rising, it’s critical we find ways to keep improving the quality of care. Part of this challenge is to understand the real-world situation of melanoma across the country. This sort of clinical research register has not been attempted before in melanoma. It’s ultimately about improving patient care and saving lives,” MIA’s Research Director Professor Graham Mann said.

During the launch, MIA also updated progress on world-first research into treatment for melanoma brain metastases funded by money raised during the 2014 Melanoma March.

The ground-breaking ‘ABC Trial’, supported by Australia and New Zealand Melanoma Trials Group (ANZMTG), is comparing the use of various immunotherapies in patients with melanoma that has spread to their brain. Running since 2014, the study is showing promising early findings. Patients who once were given just months to live are now surviving longer than a year.

“It’s only early days, but so far we are seeing a tripling of life expectancy for some patients with melanoma that has spread to the brain. There are also added benefits because this kind of work is a world first. Everything we are using is unique – we’re developing new techniques to investigate and learn from the patients’ blood and tumour samples, together with much more advanced brain imaging, which is allowing us to stay at the forefront of research," MIA's Deputy Director Associate Professor Jonathan Stretch said.

Melanoma March events will be hosted in these 24 locations nationally from February 27–April 10, 2016:

VIC:        Melbourne

ACT:       Canberra

QLD:      Bribie Island, Brisbane, Cairns, Coolangatta, Townsville

SA:         Adelaide, Port Lincoln

NT:         Darwin

WA:       Bunbury, Karratha, Perth CBD, Rockingham

NSW:     Bathurst, Bonny Hills, Forster Tuncurry, Gosford, Manly, Picton, Wagga Wagga, Western Sydney, Wollongong

TAS:       Devonport.

For more information about Melanoma March please visit: www.melanomamarch.org.au

Download press release.

 

 

 

SAVE THE DATE - Sydney Melanoma Information Forum
06 Nov 2019

SAVE THE DATE - Sydney Melanoma Information Forum

SAVE THE DATE: We are delighted to partner with Melanoma Patients Australia in hosting a Patient Information Session at The Poche Centre on 6th November.

Team Melanoma smashes City2Surf
16 Aug 2019

Team Melanoma smashes City2Surf

We want to thank every member of Team Melanoma and everyone who donated to them. With your help, we are moving closer to our goal of zero deaths from melanoma!

Ready to run over melanoma at City2Surf 2019
08 Aug 2019

Ready to run over melanoma at City2Surf 2019

Lauren O'Brien tells us why she's running for a cause close to her heart

Community Fundraising July Wrap-Up
01 Aug 2019

Community Fundraising July Wrap-Up

MIA could not do what we do without the incredible support and effort of our community fundraisers. We’d like to highlight some of the wonderful events organised by our community in the month of July that are helping us move closer to our goal of zero deaths from melanoma.

Breast cancer drug may hold key to tackling most deadly type of melanoma
23 Jul 2019

Breast cancer drug may hold key to tackling most deadly type of melanoma

An international study, led by researchers from Melanoma Institute Australia, QIMR Berghofer Medical Research Institute and The University of Sydney as part of the Australian Melanoma Genome Project, has discovered that a drug traditionally used to treat a type of breast cancer may hold the key to treating an aggressive and deadly form of melanoma.

MIA takes centre stage at leading cancer conference
05 Jun 2019

MIA takes centre stage at leading cancer conference

Researchers from Melanoma Institute Australia took centre stage at the American Society of Clinical Oncology Annual Meeting in Chicago. Results presented by MIA’s contingent have the potential to create better patient outcomes and change the way advanced melanoma is treated .

International Clinical Trials Day 2019
20 May 2019

International Clinical Trials Day 2019

Today is International Clinical Trials Day – a day to recognise and thank the amazing people who conduct, organise, and coordinate clinical trials.

Emma Betts' legacy will live on
17 May 2019

Emma Betts' legacy will live on

“I’m the age Emma was when she passed away. It almost feels unfair, that she has to not be here for me to be able to do this. But I will use this opportunity to push as hard as I can to reach our collective goal of zero deaths from melanoma.”

Support PBS listing for three adjuvant treatments of resected Stage III melanoma
13 May 2019

Support PBS listing for three adjuvant treatments of resected Stage III melanoma

As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions in support of the PBS listing.

Support PBS listing for pembrolizumab
06 May 2019

Support PBS listing for pembrolizumab

As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions in support of the PBS listing.

How are the Premier's Awards helping cancer researchers?
02 May 2019

How are the Premier's Awards helping cancer researchers?

MIA had four winners in the 2017 Premiers Awards. Find out how winning has influenced their work over the past year.

Cancer Council awards Melanoma Institute Australia researchers funding for ground-breaking cancer research projects
19 Mar 2019

Cancer Council awards Melanoma Institute Australia researchers funding for ground-breaking cancer research projects

Almost $9 million of new funding was awarded to 13 ground-breaking cancer research projects at the 2019 Cancer Council NSW Research Awards.

Making a difference to many
15 Mar 2019

Making a difference to many

Georgina V. Long is co-medical director of Melanoma Institute Australia and Chair of Melanoma Medical Oncology and Translational Research. She is the first woman president of the Society for Melanoma Research.

Aussie icon Sophie Monk calls on Australians to get behind Melanoma March
26 Feb 2019

Aussie icon Sophie Monk calls on Australians to get behind Melanoma March

Quintessential Aussie girl and media personality Sophie Monk has been announced as a National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.

Melanoma breakthrough paves way for personalised treatment for all cancer patients
14 Feb 2019

Melanoma breakthrough paves way for personalised treatment for all cancer patients

Australian researchers have for the first time identified specific cells and receptors in the immune system which predict how a patient will respond to treatment with immunotherapies, potentially paving the way for the development of personalised therapy for all cancer patients.

Melanoma March announces 2019 Principal Partner
07 Feb 2019

Melanoma March announces 2019 Principal Partner

Melanoma March is thrilled to introduce Ricky as our official Principal Partner for 2019!

Swimming champion Cate Campbell spearheads national campaign to save lives from melanoma
05 Feb 2019

Swimming champion Cate Campbell spearheads national campaign to save lives from melanoma

World record holder, Olympian and Australian swimming champion Cate Campbell has been announced as National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.

MIA experts collaborate on groundbreaking research
16 Jan 2019

MIA experts collaborate on groundbreaking research

MIA's expertise was essential to a recent Nature publication spearheaded by Perth’s Telethon Kids Institute and The University of Melbourne.

World-leading pathologist Associate Professor Michael Tetzlaff visits MIA
20 Dec 2018

World-leading pathologist Associate Professor Michael Tetzlaff visits MIA

MIA is delighted to be hosting the MD Anderson pathologist on his first ever trip to Australia.

Possible PBS listing for dabrafenib and trametinib
18 Dec 2018

Possible PBS listing for dabrafenib and trametinib

Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for dabrafenib and trametinib.